Skip to content

Clinical trials

Hematologic Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Brazil Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20101
20111
20161
20182
20202
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Federal University of Health Science of Porto Alegre2
BeOne Medicines1
Bristol-Myers Squibb1
Federal University of Rio Grande do Sul1
Gamida Cell ltd1
Hospital Israelita Albert Einstein1
Sanofi1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms15
Leukemia3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma3
Bone Marrow Diseases2
Fatigue2
Graft vs Host Disease2
Leukemia, Myeloid2
Leukemia, B-Cell1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.